Table 1.
Characteristics of the study population.
| KERRYPNX | Total | Developmental Group | Validation Group | p-Value * |
|---|---|---|---|---|
| Number of patients | 581 | 207 | 374 | |
| Age (years) † | 27.7 ± 7.2 | 27.6 ± 6.9 | 27.8 ± 7.3 | 0.661 |
| Sex | ||||
| Male | 413 (71.1) | 132 (63.8) | 282 (74.8) | 0.004 |
| Hepatic steatosis | 0.816 | |||
| None | 492 (84.7) | 177 (85.5) | 315 (84.2) | |
| Mild | 87 (15.0) | 29 (14.0) | 58 (15.5) | |
| Moderate | 2 (0.3) | 1 (0.5) | 1 (0.3) | |
| BMI (kg/m2) † | 22.9 ± 2.9 | 22.5 ± 2.9 | 23.1 ± 2.9 | 0.015 |
| Height (cm) † | 170.4 ± 8.1 | 169.9 ± 8.4 | 170.7 ± 7.9 | 0.268 |
| Weight (kg) † | 66.8 ± 11.4 | 65.4 ± 11.7 | 67.6 ± 11.1 | 0.022 |
| Type of liver graft | 0.151 | |||
| RLG without MHV | 559 (96.2) | 196 (94.7) | 363 (97.1) | |
| RLG with MHV | 22 (3.8) | 11 (5.3) | 11 (2.9) | |
| Interval between CT and graft donation (days) † | 30.6 ± 19.0 | 30.9 ± 18.8 | 30.4 ± 19.1 | 0.728 |
| Graft weight (g) † | 748.8 ± 129.3 | 728.1 ± 123.5 | 760.2 ± 131.2 | 0.004 |
Unless otherwise indicated, data are shown as the number of patients, with percentages in parentheses. RLG = right-lobe graft, MHV = middle hepatic vein. * p-values for comparisons between the development and validation groups; † Mean ± standard deviation.